75 records, the earliest from 16 Aug 2012. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
75 shown.
Sign in to see more, or upgrade your plan to see the full history.
Sign in
| Date | Category | Subject |
|---|
| 26 Jul 2018 12:59 | Delisting |
Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Rule 21(2) b of Securities Contract (Regulations) Rules, 1957 , it has been decided to delist (withdraw the admission to dealings in) equity shares of the Arvind Remedies Limited w.e.f. August 08, 2018 as per Chapter V of SEBI (Delisting of Equity Shares) Regulations, 2009. |
| 28 Feb 2018 13:14 | Public Notice - Compulsory Delisting |
Members of the Exchange are hereby informed that the Exchange on February 28, 2018 has issued public notice in the newspaper for�� proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements). |
| 17 Aug 2016 13:03 | Appointment |
Arvind Remedies Limited has informed the Exchange that the decision to appoint Dr. Timothy and Mr. M Vasudevan as Additional Directors of the Company in view of the investment by M/s. Global Allied pharmaceuticals LLC.However, since the investment did not take place, the appointments were not effected.Further, the Directors information on the company from the company site the names of the above persons as directors, and in view of the above, . |
| 17 Aug 2016 07:37 | Financial Result Updates |
Arvind Remedies Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016. |
| 17 Aug 2016 06:30 | Outcome of Board Meeting |
Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 12, 2016, decided to defer all other items, intimated vide Company's letter dated August 02, 2016 to the next meeting. |
| 30 May 2016 07:38 | Disclosure under SEBI Takeover Regulations |
Dr B Arvind Shah has submitted to the Exchange vide letter dated May 25, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. |
| 26 May 2016 05:56 | Disc. under Reg.30 of SEBI (SAST) Reg.2011 |
Dr B Arvind Shah has submitted to the Exchange vide letter dated May 13, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. |
| 1 Apr 2016 10:58 | AGM/Book Closure |
Arvind Remedies Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from April 15, 2016 to April 18, 2016 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on April 18, 2016. |
| 30 Dec 2015 13:57 | Extension of Annual General Meeting |
Arvind Remedies Limited has informed the Exchange that the company has obtained further extension upto March 2016 to hold the Annual General Meeting for the financial year ended June 30, 2015. A copy of the approval dated December 23, 2015 received from the Registrar of Companies is enclosed. |
| 27 Nov 2015 03:08 | Outcome of Board Meeting |
Arvind Remedies Limited has informed the Exchange that the Board Meeting held on November 26, 2015 has discussed in detail reasons for the delay, the financial constraints through which the company is passing through, and the restructuring request with the banks through investor by SDR route for which negotiations are going on. Board felt that instead of considering unaudited results for the quarters ended March 31, 2015 and June 30, 2015 to avoid the notice of suspension, since the audit is going on, it is advisable to come out with the audited results for these quarters, along with the unaudited financial results for the quarter ended September 30, 2015. After considering the status of audit, it was decided that next Board meeting be convened on December 10, 2015. |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
